This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like wh Read More
Related Posts
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early…
Some patients with obstructive sleep apnea and obesity who took the highest dose of Zepbound achieved "disease resolution" in the two trials.
Huaweis revenue barely rose in the third quarter despite phone and car sales growth CNBC
Chinese tech giant Huawei reported revenue figures Friday that showed only a 1% increase in the third quarter from a year ago, according to CNBC calculations.
Dow rises 200 points Tuesday as traders await key inflation data Live earnings CNBC
U.S. stocks rose Tuesday, after the major averages snapped a three-day decline, as traders awaited key inflation data slated for release later in the week.